LONDON, UK / ACCESSWIRE / October 28, 2016 / Active Wall St. announces its post-earnings coverage on Illinois Tool Works Inc. (NYSE: ITW). The company released its financial results for the third quarter fiscal 2016 on October 20 2016. Illinois Tool Works topped revenue and earnings expectations and posted record quarterly operating margin of 23.1% and record quarterly operating income of $808 million. Register with us now for your free membership at: http://www.activewallst.com/register/.

Today, AWS is promoting its earnings coverage on ITW. Get our free coverage by signing up to http://www.activewallst.com/registration-3/?symbol=ITW.

Earnings Reviewed

For the three months ended on September 30th, 2016, Illinois Tool Works reported diluted earnings per share (EPS) of $1.50, an 8% increase compared to the year-ago period. Earnings topped market expectations by a penny and also exceeded the mid-point of guidance range of $1.42 per share to $1.52 per share. The bottom-line also benefitted from the 3.2% reduction in the company’s share count due to its ongoing share buyback activity. Earnings were also boosted by its enterprise initiatives; however, currency translation reduced EPS by $0.02 in the quarter.

Illinois Tool Works’ Q3 2016, revenues totaled approximately $3.50 billion, higher by 4.2% compared to the year ago period and surpassed analysts’ estimate of $3.49 billion. The improvement was driven by 3.5% positive impact from divestiture gains and 1.6% organic revenue growth.

The company’s operating margin increased 40 basis points to 23.1%, including 80 basis points of margin dilution from its Q3 2016 acquisition of Engineered Fasteners & Components (EF&C). Excluding the EF&C dilution impact, Q3 2016 operating margin was 23.9%. Operating income of $808 million was up 6%, and after-tax return on invested capital increased by 140 basis points to 23%. Organic revenue increased 2% and the company’s ongoing Product Line Simplification (PLS) activities reduced organic revenue growth by approximately 1% percentage point.

Segment Results

Illinois Tool Works’ Test & Measurement and Electronics segment’s revenues increased 5.3% on y-o-y basis to $516 million for Q3 2016, while revenues from Automotive Original Equipment Manufacturer unit grew 24.8% to $765 million. The company’s Food Equipment segment generated revenues of $544 million, down 1.3% compared to the year ago period.

During Q3 2016, Illinois Tool Works’ Welding unit reported revenues of $361 million, down 8.9% from Q3 2015. Construction Products’ revenues were up 1.6% to $415 million, while revenues of $477 million from Specialty Products reflected a decline of 0.6%. Polymers & Fluids’ revenues of $422 million were flat y-o-y.

All seven segments achieved operating margin at or above 21% with Food Equipment at 27.4%, Welding at 26.5%, Specialty Products at 26.1%, Automotive OEM at 21.8% (25.5% excluding EF&C), Construction at 22.6%, and Test & Measurement/Electronics and Polymers & Fluids both at 21%.

Looking Forward

Illinois Tool Works raised its FY16 earnings forecast in the range of $5.56 to $5.66, a y-o-y increase of 9% at the mid-point. Operating margin is projected to exceed 22.5%. For Q4 2016, the company expects GAAP EPS to be in a range of $1.31 to $1.41, an increase of 11% at the mid-point. Organic revenue is expected to be 0% to 2%, and operating margin to be approximately 21.5%.

Margins

During Q3 2016, Illinois Tool Works’ cost of sales increased 3.8% on y-o-y basis, representing 58% of total revenue compared with 58.2% in Q3 2015. Selling, administrative, and research and development expenses, as a percentage of total revenue, came in at 17.3%.

Balance Sheet

As of September 30th, 2016, Illinois Tool Works had cash and cash equivalents of approximately $2.30 billion, compared to $2.6 billion in the previous quarter. The company’s long-term debt increased 0.5% sequentially to $6,329 million. In the quarter, Illinois Tool Works generated net cash of $624 million from its operating activities, down 11.6% y-o-y. Free cash flow was solid at 101% of net income. Share repurchases totaled $500 million and the company announced an 18% dividend increase on August 5, 2016.

Stock Performance

Illinois Tool Works’ share price finished yesterday’s trading session at $113.32, slightly down 0.05%. A total volume of 1.67 million shares exchanged hands, which was higher than the 3 months average volume of 1.51 million shares. The stock has advanced 9.63% and 25.79% in the last six months and past twelve months, respectively. Furthermore, since the start of the year, shares of the company have gained 24.30%. The stock is trading at a PE ratio of 21.09 and has a dividend yield of 2.29%.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 447869

LONDON, UK / ACCESSWIRE / October 28, 2016 / Active Wall St. announces the list of stocks for today’s research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Asset Management industry. Companies recently under review include Tricon Capital, INFOR Acquisition, CI Financial, and Fiera Capital. Get all of our free research reports by signing up at: http://www.activewallst.com/register/.

At the close of the Canadian markets on Thursday, October 27, 2016, the Toronto Exchange Composite index ended the trading session at 14,833.75, 0.18% higher from its previous closing price.

The Financials Index was also in the black, closing the day at 261.14, up 0.22%.

Active Wall St. has initiated research reports on the following equities: Tricon Capital Group Inc. (TSX: TCN), INFOR Acquisition Corporation (TSX: IAC-A), CI Financial Corporation (TSX: CIX), and Fiera Capital Corporation (TSX: FSZ). Register with us now for your free membership and research reports at: http://www.activewallst.com/register/.

Tricon Capital Group Inc.

On Thursday, shares in Toronto, Canada-based Tricon Capital Group Inc. recorded a trading volume of 179,799 shares. The stock ended the day 0.44% lower at $9.00. Tricon Capital Group Inc.’s stock is trading below its 50-day and 200-day moving averages. The stock’s 50-day moving average of $9.19 is above its 200-day moving average of $9.08. Shares of the Company, which specializes in making investments in the residential sector with a focus on for-sale housing and financially distressed investments in primarily entitled land, finished and partially-finished lots, and standing home inventory, largely through the purchase of deeply discounted bank notes, REO, bankruptcy sales and sales from other motivated buyers at significant discounts to peak pricing, are trading at PE ratio of 11.90. See our research report on TCN.TO at: http://www.activewallst.com/registration-3/?symbol=TCN.

INFOR Acquisition Corp.

Toronto, Canada headquartered INFOR Acquisition Corp.’s stock finished Thursday’s session flat at $9.90 with a total volume of 18,700 shares traded. Over the last one month and the previous one year, INFOR Acquisition’s shares have advanced 0.30% and 2.06%, respectively. Shares of the Company, which intends to acquire one or more businesses or assets by way of a merger, share exchange, asset acquisition, share purchase, reorganization, or any other similar business combination, are trading above its 200-day moving average. INFOR Acquisition’s 50-day moving average of $9.93 is above its 200-day moving average of $9.85. The complimentary research report on IAC-A.TO at: http://www.activewallst.com/registration-3/?symbol=IAC.A.

CI Financial Corp.

Toronto, Canada-based CI Financial Corp.’s stock advanced 1.81%, to close the day at $24.47. The stock recorded a trading volume of 508,936 shares, which was above its three months average volume of 481,095 shares. CI Financial’s shares are trading below their 50-day and 200-day moving averages. Moreover, the stock’s 200-day moving average of $26.46 is greater than its 50-day moving average of $24.90. Shares of the Company, which through its subsidiaries, the firm manages separate client focused equity, fixed income, and alternative investments portfolios, are trading at a PE ratio of 13.16. Register for free and access the latest research report on CIX.TO at: http://www.activewallst.com/registration-3/?symbol=CIX.

Fiera Capital Corp.

On Thursday, shares in Montréal, Canada-based Fiera Capital Corp. ended the session 0.41% lower at $12.06 with a total volume of 9,863 shares traded. Fiera Capital’s shares have advanced 1.77% in the past one year. The stock is trading below its 50-day and 200-day moving averages. Furthermore, the stock’s 200-day moving average of $12.78 is greater than its 50-day moving average of $12.44. Shares of Fiera Capital, which provides its services to institutional investors, mutual funds, charitable organizations, and private clients, are trading at a PE ratio of 27.47. Get free access to your research report on FSZ.TO at: http://www.activewallst.com/registration-3/?symbol=FSZ.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 447873

Bets Big on “Internet-Of-Things” and Expands Presence in Auto Sector

LONDON, UK / ACCESSWIRE / October 28, 2016 / Active Wall St. blog coverage looks at the headline from QUALCOMM Inc. (NASDAQ: QCOM) as the company announced on October 27, 2016, the decision to acquire NXP Semiconductors N.V. (NASDAQ: NXPI) in an all cash deal. The total enterprise value of the deal is approximately $47 billion. Register with us now for your free membership and blog access at: http://www.activewallst.com/register/.

Today, AWS is promoting its blog coverage on QCOM and NXPI. Get all of our free blog coverage and more by clicking on the link below:

http://www.activewallst.com/registration-3/?symbol=QCOM

http://www.activewallst.com/registration-3/?symbol=NXPI

Terms of Agreement

As per the agreed terms, one of Qualcomm’s subsidiaries will acquire all outstanding shares of NXP Semiconductors (“NXP”) via a tender offer. It will pay $110 per share in cash to the NXP’s shareholders. Qualcomm plans to finance the deal using a mix of cash in hand as well as fresh debt. The tender offer is not subject to any financing conditions. However, the tender document stipulates that Qualcomm should manage to acquire at least 95% of outstanding shares of NXP or at least 80% of shares of NXP in case it gets shareholders’ approval of the tender conditions. The deal is expected to close by end of year 2017 subject to fulfilment of statutory approvals and regulations.

Commenting on the acquisition, Steve Mollenkopf, CEO of Qualcomm, said:

“By joining Qualcomm’s leading SoC capabilities and technology roadmap with NXP’s leading industry sales channels and positions in automotive, security and IoT, we will be even better positioned to empower customers and consumers to realize all the benefits of the intelligently connected world.”

Benefits for Qualcomm

Financial Benefits

The merged Qualcomm/ NXP entity is expected to have revenues of over $30 billion annually. The transaction will add significantly to Qualcomm’s adjusted earnings after the close of the deal. Qualcomm expects $500 million in terms of cost synergies annually within two years of the deal’s closure. Qualcomm expects the transaction to be significantly accretive to non-GAAP EPS on finalization of the deal. The deal is structured in such a manner that Qualcomm can get maximum tax benefit by using the offshore cash flow. Also since the deal is through the subsidiary, using cash in hand and fresh debt, Qualcomm’s balance sheet will continue to remain strong.

Other Benefits

Qualcomm is the 3rd largest semiconductor company in the world with revenues around US$27 billion. Qualcomm’s primary revenue is from sale of customised chips for smartphones and patent licensing agreements. It has been looking at new opportunities for growth and revenues due to the slowdown in the smartphone market and cutthroat competition from Chinese and Taiwanese manufacturers. NXP on the other hand is a market leader in Automotive, Internet of Things, Security and Networking. The merger with NXP will allow Qualcomm to gain a foothold in these lucrative segments. NXP had acquired Freescale Semiconductors in March 2015 and had become a one stop shop for automotive intelligence. It also manufactures specialized chips for radio applications, near field communications (NFC), i.e. technology required for stuff like payments using mobile phones (Andriod Pay, Apple Pay etc.) and keyless car door unlocking etc. On completion of the deal, Qualcomm gets access to NXP’s seven factories, located in the five countries that manufacture silicon chips, and seven facilities, that package and test chips before they are installed.

With the acquisition, Qualcomm will grow from a chip manufacturer to a diversified company which offers products including microcontrollers, discrete components and logic, power management, RF, sensors and automotive products. The big bet is on the driverless technology where NXP has a wide range of products including advanced driver assistance systems (ADAS), access, infotainment, in-vehicle networking, body, chassis and safety applications.

Stock Performance

On Thursday, Investors were enthusiastic about the Qualcomm/ NXP merger which reflected on the stock performance. QUALCOMM’s stock closed the trading session at $70.09, climbing 2.77% from its previous closing price of $70.09. A total volume of 33.92 million shares have exchanged hands, which was higher than the 3-month average volume of 8.74 million shares. The company’s stock price advanced 10.46% in the last month, 12.95% in the past three months, and 41.26% in the previous six months. Furthermore, since the start of the year, shares of the company have surged 44.10%. The stock is trading at a PE ratio of 20.55 and has a dividend yield of 3.02%.

NXP Semiconductors’ share price finished yesterday’s trading session at $99.08, slightly up 0.43%. A total volume of 36.61 million shares exchanged hands, which was higher than the 3 months average volume of 4.17 million shares. The stock has advanced 17.83% and 16.18% in the last three months and past six months, respectively. Furthermore, since the start of the year, shares of the company have gained 17.60%. The stock is trading at a PE ratio of 25.64 and currently has a market cap of $35.22 billion.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 447877

LONDON, UK / ACCESSWIRE / October 28, 2016 / Active Wall St. announces the list of stocks for today’s research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Business Services industry. Companies recently under review include Thomson Reuters, Aimia, Intermap Technologies, and Ritchie Bros. Auctioneers. Get all of our free research reports by signing up at: http://www.activewallst.com/register/.

At the close of the Canadian markets on Thursday, October 27, 2016, the Toronto Exchange Composite index ended the trading session at 14,833.75, 0.18% higher from its previous closing price.

The Industrials Index was also in the black, closing the day at 193.65, up 0.21%.

Active Wall St. has initiated research reports on the following equities: Thomson Reuters Corporation (TSX: TRI), Aimia Inc. (TSX: AIM), Intermap Technologies Corporation (TSX: IMP), and Ritchie Bros. Auctioneers Inc. (TSX: RBA). Register with us now for your free membership and research reports at: http://www.activewallst.com/register/.

Thomson Reuters Corp.

On Thursday, shares in New York headquartered Thomson Reuters Corp. ended the session 0.19% lower at $52.96 with a total volume of 720,732 shares traded. Thomson Reuters’ shares are trading below its 50-day and 200-day moving averages. Furthermore, the stock’s 200-day moving average of $53.65 is greater than its 50-day moving average of $53.53. Shares of Thomson Reuters, which provides news and information for professional markets worldwide, are trading at a PE ratio of 31.51. See our research report on TRI.TO at: http://www.activewallst.com/registration-3/?symbol=TRI.

Aimia Inc.

Montreal, Canada headquartered Aimia Inc.’s stock fell 1.83%, to finish Thursday’s session at $7.52 with a total volume of 313,609 shares traded. Shares of Aimia, which through its subsidiaries, operates as a data-driven marketing and loyalty analytics company worldwide, are trading below its 50-day and 200-day moving averages. Aimia’s 200-day moving average of $8.24 is above its 50-day moving average of $8.18. The complimentary research report on AIM.TO at: http://www.activewallst.com/registration-3/?symbol=AIM.

Intermap Technologies Corp.

Englewood, Colorado headquartered Intermap Technologies Corp.’s stock declined 5.56%, to close the day at $0.09. The stock recorded a trading volume of 219,696 shares. Shares of Intermap Technologies, which provides geospatial information solutions with its cloud-based Orion platform, are trading below their 50-day and 200-day moving averages. Moreover, the stock’s 200-day moving average of $0.24 is greater than its 200-day moving average of $0.13. Register for free and access the latest research report on IMP.TO at: http://www.activewallst.com/registration-3/?symbol=IMP.

Ritchie Bros. Auctioneers Inc.

On Thursday, shares in Burnaby, Canada headquartered Ritchie Bros. Auctioneers Inc. recorded a trading volume of 90,295 shares. The stock ended the day 0.30% lower at $46.08. Ritchie Bros. Auctioneers’ stock has advanced 2.74% in the last one month and 6.18% in the previous three months. Furthermore, the stock has gained 35.01% in the past one year. The Company is trading above its 50-day and 200-day moving averages. The stock’s 50-day moving average of $45.87 is above its 200-day moving average of $42.17. Shares of the Company, which together with its subsidiaries, sells industrial equipment and other assets for the construction, agricultural, transportation, energy, mining, forestry, material handling, marine, and real estate industries through its unreserved auctions and online marketplaces, are trading at PE ratio of 36.08. Get free access to your research report on RBA.TO at: http://www.activewallst.com/registration-3/?symbol=RBA.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 447872

LONDON, UK / ACCESSWIRE / October 28, 2016 / Active Wall St. announces its post-earnings coverage on Walgreens Boots Alliance, Inc. (NASDAQ: WBA). The company posted its financial results for the fourth quarter and fiscal year 2016 on October 20 2016. The largest U.S. drugstore operator by store count reported a jump in earnings and pushed out the deadline to close the $9.4 billion merger with Rite Aid Corp. (NYSE: RAD). Register with us now for your free membership at: http://www.activewallst.com/register/.

Today, AWS is promoting its earnings coverage on WBA; touching on RAD. Get our free coverage by signing up to

http://www.activewallst.com/registration-3/?symbol=WBA

http://www.activewallst.com/registration-3/?symbol=RAD

Earnings Reviewed

For the three months ended on August 31st, 2016, Walgreens Boots Alliance reported net income of $1.03 billion, or $0.95 per share, up from $26 million, or $0.2 per share, for the same period last year. Adjusted Q4 FY16 net earnings increased 20.3% to $1.2 billion compared with the same quarter a year ago. Adjusted diluted net earnings per share for the quarter increased 21.6% to $1.07 compared to the same quarter a year ago exceeding analysts’ forecasts of $0.99 per share.

Sales in Q4 FY16 were $28.6 billion, an increase of 0.4% over the year-ago quarter; however sales came in below market forecasts of $29.11 billion. Operating income in Q4 FY16 was $1.1 billion, an increase of 36.4% from the same quarter a year ago.

FY16 Results

For FY16, Walgreens Boots Alliance saw earnings decreased 1.1% to $4.2 billion, while diluted net earnings per share dropped 4.5% to $3.82 compared with the prior year. Adjusted net earnings attributable to Walgreens Boots Alliance in fiscal 2016 increased 22.6% to $5.0 billion compared to the prior year. The company’s sales increased 13.4% to $117.4 billion in fiscal 2016 compared to the prior year. Operating income for FY16 came in at $6.0 billion, an increase of 28.6% from the prior year.

Segment Results

Walgreens Boots Alliance’s Retail Pharmacy USA division had Q4 FY16 sales of $20.7 billion, up 4.0% over the year ago quarter. Sales in comparable stores increased 3.2% compared to Q4 FY15. Pharmacy sales, which accounted for 69% of the division’s sales in the quarter, increased 6.2% on y-o-y basis. The division filled 229.5 million prescriptions adjusted to 30-day equivalents in the quarter, an increase of 3.7% over Q$ FY16. Adjusted operating income in Q4 FY16 increased 4.4% over the year-ago quarter to $1.1 billion. The increase in adjusted operating income was primarily driven by increased pharmacy volume, procurement efficiencies and cost controls.

The Retail Pharmacy International division of the company reported sales of $3.0 billion in Q4 FY16, down by 10.9% over the year-ago quarter due to the negative impact of currency translation, with sales increasing by 1.4% on a constant currency basis. On a constant currency basis, comparable store sales dropped 0.6% compared to the year-ago quarter. Operating income in Q4 FY16 increased 4.6% over the year-ago quarter to $205 million.

Walgreens Boots Alliance’s Pharmaceutical Wholesale segment had Q4 FY16 sales of $5.4 billion, a drop of 6.2% over the year-ago quarter. On a constant currency basis, excluding acquisitions and dispositions, comparable sales increased 2.9%. Operating income in the reported quarter was $156 million, which included $34 million from the company’s equity earnings in AmerisourceBergen compared to $133 million in the year-ago period.

Cash Matters

Walgreens Boots Alliance’s net cash provided by operating activities was $2.7 billion, and free cash flow was $2.2 billion in Q4 FY16. For FY16, net cash provided by operating activities increased $2.2 billion to $7.8 billion, and free cash flow increased $2.1 billion to $6.5 billion compared to the prior year.

Update on Rite Aid Acquisition

In a separate press release on the same day, Walgreens Boots Alliance and Rite Aid announced that they have mutually agreed to extend the end date of their merger agreement from 27 October 2016 to 27 January 2017. The companies now expect the transaction will close in early calendar 2017.

On 27 October 2015, the companies entered into a definitive agreement under which Walgreens Boots Alliance agreed to acquire all outstanding shares of Rite Aid for $9.00 per share in cash. Walgreens Boots Alliance announced that it remains actively engaged with the Federal Trade Commission (FTC) regarding its review of the pending acquisition, and continues to expect that the most likely outcome will be that the parties will be required to divest between 500 and 1,000 stores.

Walgreens Boots Alliance continues to expect that the acquisition will be accretive to its adjusted diluted net earnings per share in the first full year after closing of the transaction. The company also continues to expect that it will realize synergies from the acquisition in excess of $1 billion, to be fully realized within three to four years of closing.

Stock Performance

On Thursday, the stock closed the trading session at $82.16, marginally falling 0.17% from its previous closing price of $82.30. A total volume of 2.78 million shares have exchanged hands. Walgreens Boots Alliance’s stock price advanced 1.86% in the last month, 4.14% in the past three months, and 4.58% in the previous six months. The stock is trading at a PE ratio of 21.49 and has a dividend yield of 1.83%.

Rite Aid’s shares were also down 1.47% on the same day, finishing at $6.69 with a total of 10.43 million shares traded for the day. The stock has market cap of $7.11 billion.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 447882

LONDON, UK / ACCESSWIRE / October 28, 2016 / Active Wall St. announces the list of stocks for today’s research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Energy sector. Companies recently under review include Parkland Fuel, PetroMaroc, Suncor Energy, and Tidewater Midstream and Infrastructure. Get all of our free research reports by signing up at: http://www.activewallst.com/register/.

On Thursday, October 27, 2016, the Toronto Exchange Composite Index was up 0.18%, finishing the day at 14,833.75. The TSX Venture Composite Index, on the other hand, closed at 775.19, down 0.03%.

Additionally, the Energy index was up by 1.77%, ending the session at 210.57.

Active Wall St. has initiated research reports on the following equities: Parkland Fuel Corporation (TSX: PKI), PetroMaroc Corporation PLC (TSX-V: PMA), Suncor Energy Inc. (TSX: SU), and Tidewater Midstream and Infrastructure Ltd. (TSX-V: TWM). Register with us now for your free membership and research reports at: http://www.activewallst.com/register/.

Parkland Fuel Corp.

Red Deer, Canada headquartered Parkland Fuel Corp.’s stock edged 0.55% higher, to close the day at $30.97. The stock recorded a trading volume of 138,051 shares. Parkland Fuel’s shares have gained 33.84% in the last three months and 37.40% in the past one year. The company’s shares are trading above their 50-day and 200-day moving averages. Moreover, the stock’s 50-day moving average of $30.65 is greater than its 200-day moving average of $25.55. Shares of the Company, which operates as an independent marketer and distributor of fuels and lubricants in Canada and the US, are trading at a PE ratio of 48.39. See our research report on PKI.TO at: http://www.activewallst.com/registration-3/?symbol=PKI.

PetroMaroc Corp. PLC

St Helier, the Channel Islands headquartered PetroMaroc Corp. PLC’s stock gained 14.29%, to finish Thursday’s session at $0.08 with a total volume of 1.80 million shares traded. Over the past three months, PetroMaroc’s shares have rallied 30.00%. Shares of the Company, which engages in the evaluation, acquisition, exploration, and development of oil and gas properties in Morocco, are trading above its 50-day and 200-day moving averages. PetroMaroc’s 50-day moving average of $0.06 is above its 200-day moving average of $0.03. The complimentary research report on PMA.V at: http://www.activewallst.com/registration-3/?symbol=PMA.

Suncor Energy Inc.

On Thursday, shares in Calgary, Canada headquartered Suncor Energy Inc. ended the session 5.66% higher at $41.61 with a total volume of 10.70 million shares traded. Shares of Suncor Energy, which operates in Oil Sands; Exploration and Production; Refining and Marketing; and Corporate, Energy Trading, and Eliminations segments, have gained 16.95% in the last one month, 18.24% in the previous three months, and 7.21% in the past one year. The stock is trading above its 50-day and 200-day moving averages. Furthermore, the company’s 50-day moving average of $36.30 is greater than its 200-day moving average of $35.77. Register for free and access the latest research report on SU.TO at: http://www.activewallst.com/registration-3/?symbol=SU.

Tidewater Midstream and Infrastructure Ltd.

On Thursday, shares in Calgary, Canada headquartered Tidewater Midstream and Infrastructure Ltd. recorded a trading volume of 374,557 shares. The stock ended the day 2.56% higher at $1.60. Tidewater Midstream and Infrastructure’s stock has advanced 7.38% in the last one month and 21.21% in the previous three months. Furthermore, the stock has gained 13.48% in the past one year. The Company is trading above its 50-day and 200-day moving averages. The stock’s 50-day moving average of $1.49 is above its 200-day moving average of $1.40. Shares of the Company, which purchases, transports, and sells natural gas liquids primarily in North America, are trading at PE ratio of 16.84. Get free access to your research report on TWM.V at: http://www.activewallst.com/registration-3/?symbol=TWM.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 447871

LONDON, UK / ACCESSWIRE / October 28, 2016 / Active Wall St. blog coverage looks at the headline from ProQR Therapeutics N.V. (NASDAQ: PRQR) as the company presented on October 27th, 2016, clinical data showing for the first time that its experimental drug QR-010 improves the function of a key protein that is defective in patients with cystic fibrosis (CF). Register with us now for your free membership and blog access at: http://www.activewallst.com/register/.

Today, AWS is promoting its blog coverage on PRQR. Get all of our free blog coverage and more by clicking on the link below:

http://www.activewallst.com/registration-3/?symbol=PRQR

Cystic Fibrosis

Cystic fibrosis is the most common fatal inherited disease in the Western world and affects an estimated 70,000 to 100,000 patients worldwide. There is no cure for CF. Disease manifestations lead to a shortened life expectancy with a median age of death of 27 years. Although over 1,900 CF-causing gene mutations have been identified, approximately 70% of all CF patients are affected by the DF508 mutation.

The Results

ProQR Therapeutics announced that clinical study PQ-010-002, a proof-of-concept study of nasal potential difference (NPD), demonstrated that QR-010 restored CFTR function in a cohort of homozygous ∆F508 CF patients. The company stated that the study met its primary endpoint in this cohort as measured by a change in total chloride response following 4 weeks of treatment with QR-010. In the compound heterozygous ∆F508 cohort, no meaningful difference was found.

ProQR also announced that clinical study PQ-010-001 completed all four single-dose cohorts. PQ-010-001 is a placebo-controlled Phase 1b study in subjects with CF homozygous for ∆F508. QR-010 was observed to be safe and well-tolerated in all four single dose cohorts. The multiple dose cohorts in this study are on-going and top line safety, tolerability and exploratory efficacy data from this study are expected in mid-2017.

“Patients with CF feel and do better when the CFTR protein channel works more normally. Our important first step in helping patients with CF was to demonstrate that QR-010 could restore CFTR function in patients with CF due to ∆F508, the most common mutation. Having achieved this major step, we have increased confidence in QR-010’s potential to make a meaningful clinical impact for patients and will move forward with an aggressive development plan,” said Noreen R. Henig, M.D., Chief Development Officer of ProQR.

What is PQ-010-002 study?

PQ-010-002 was an open-label, proof-of-concept study evaluating the effect of QR-010 on the nasal potential difference (NPD) assay, an important measurement of CFTR function. The study was conducted in 5 NPD specialized centers in the US and Europe. QR-010 was applied topically to the nasal mucosa 12 times over a period of 4 weeks. Primary endpoint for each cohort was the change from baseline in CFTR mediated total chloride transport as measured by NPD.

In the per-protocol population of subjects homozygous for the ΔF508 mutation meeting the pre-specified inclusion criteria (n=7), the average change from baseline in NPD at day 26 was statistically significant, -4.1 mV (p=0.0389). This finding was supported by a change in sodium channel activity and other sensitivity analyses of the NPD measurements, all pointing to strong evidence of restoration of CFTR activity.

In subjects’ compound heterozygous for the ΔF508 mutation, the average change from baseline in NPD was not significantly different at day 26.

The PQ-010-001 Study

PQ-010-001 is a Phase 1b randomized, double-blind, placebo-controlled, dose-escalation 28-day study currently enrolling patients in more than 20 centers in North America and Europe. This study evaluates the safety, tolerability, and pharmacokinetics of single and multiple ascending doses of inhaled QR-010 in a total of 64 CF patients homozygous for the ΔF508 mutation. Exploratory efficacy endpoints in the multiple dose cohorts include sweat chloride, weight gain, CFQ-R Respiratory Symptom Score and lung function, measured by FEV1. The single dose portion of the study consisting of 4 cohorts has been completed. No dose-limited toxicity was observed up to the highest dose tested. The dose escalating multiple-dose study is currently enrolling cohort 6 and top line results are expected to be available in mid-2017.

What is QR-010?

QR-010 is a first-in-class RNA-based oligonucleotide designed to address the underlying cause of the disease by targeting the mRNA in CF patients that have the DF508 mutation. The DF508 mutation is a deletion of three of the coding base pairs, or nucleotides, in the CFTR gene, which results in the production of a misfolded CFTR protein that does not function normally. QR-010 is designed to bind to the defective CFTR mRNA and to restore CFTR function. QR-010 is designed to be self-administered via an optimized eFlow® Nebulizer (PARI Pharma GmbH). QR-010 has been granted orphan drug designation in the United States and the European Union and fast-track status by the FDA. The QR-010 project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 633545.

The latest results paves the way for a phase II trial and with solid results the company is optimistic moving ahead into the said trial on the front foot.

Stock Performance

ProQR Therapeutics’ share price finished yesterday’s trading session at $6.15, flat for the day. A total volume of 3.14 million shares exchanged hands, which was higher than the 3 months average volume of 38.63 thousand shares. Shares of the company have advanced 25.77% and 11.21% in the last three months and past six months, respectively. The stock currently has a market cap of $142.99 million.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 447878